Engystol T ad us. vet.
Engystol T ad us. vet.
Authorised
- SULFUR D4
- SULFUR D4
- VINCETOXICUM E CINERE D30
- VINCETOXICUM HIRUNDINARIA D6
- VINCETOXICUM HIRUNDINARIA D6
- VINCETOXICUM HIRUNDINARIA D6
Product identification
Medicine name:
Engystol T ad us. vet.
Active substance:
- SULFUR D4
- SULFUR D4
- VINCETOXICUM E CINERE D30
- VINCETOXICUM HIRUNDINARIA D6
- VINCETOXICUM HIRUNDINARIA D6
- VINCETOXICUM HIRUNDINARIA D6
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
SULFUR D436.00milligram(s)1.00Tablet
-
SULFUR D436.00milligram(s)1.00Tablet
-
VINCETOXICUM E CINERE D3012.00milligram(s)1.00Tablet
-
VINCETOXICUM HIRUNDINARIA D672.00milligram(s)1.00Tablet
-
VINCETOXICUM HIRUNDINARIA D672.00milligram(s)1.00Tablet
-
VINCETOXICUM HIRUNDINARIA D672.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Homeopathic Registration
Marketing authorisation holder:
- Biologische Heilmittel Heel GmbH
Marketing authorisation date:
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402677.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/08/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/08/2024
How useful was this page?: